Found 0 matching trials
Life Style Modification Medical and Surgical Management in Patients With Obesity N/A In this is an observational study, obese patients that administed and follo...
Show More Location
Marmara University Medical School Section of Endocrinology and Metabolism
Learn More & Join Trial
Incretin-based Therapy in Late Preclinical Type 1 Diabetes PHASE2 The objective of the trial is to study whether daily treatment with liraglu...
Show More Location
University of Oulu and Oulu University Hospital, Dept of Children and Adolescents
Learn More & Join Trial
A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden N/A This trial is conducted in Europe. The aim of this study is to investigate ...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus PHASE3 Type 2 diabetes (T2DM) is related to reduced pulmonary function. As experim...
Show More Location
Hospital Universitari Germans Trias i Pujol
Learn More & Join Trial
Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg NA Background/Objectives: Only 1% of the clinically eligible subjects receive ...
Show More Location
Catholic University School of Medicine
Learn More & Join Trial
Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus PHASE4 The purpose of this study is to investigate the therapeutic effect of Lirag...
Show More Location
Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University
Learn More & Join Trial
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy PHASE3 This trial is conducted in Asia, Europe and the United States of America (U...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients? PHASE2 Metabolic disturbances, obesity and life-shortening cardiovascular morbidit...
Show More Location
Psychiatric Centre Rigshospitalet
Learn More & Join Trial
To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes PHASE2 This study is the first administration of GSK2890457 in humans. The study w...
Show More Location
GSK Investigational Site
Learn More & Join Trial
The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease PHASE3 Diabetic kidney disease (DKD) is a devastating complication of diabetes, th...
Show More Location
St Vincent's Healthcare Group
Learn More & Join Trial